Home

Rosemary A Crane

CIK 1443343 · CEO and President · last filed 2026-06-08

Rosemary A Crane is a CEO and President who has filed 47 SEC Form 4 insider transactions across 9 companies since 2008. The most recent filing, for TEVA, was dated Jun 8, 2026. Across all open-market trades the lifetime net is +$16.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $5.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.12M

Companies

9

Total Filings

47

Lifetime Open-Market Net

$16.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TEVA Director 127,739 $34.78 $4.44M -$34.0K 19 2026-06-08
CERT Director 45,672 $7.83 $357.6K $0 5 2026-05-15
TARS Director 5,350 $58.71 $314.1K $0 6 2024-06-25
Catalent, Inc. (CTLT) Delisted Director 23,873 $63.48 $1.52M $0 7 2023-10-31
PDSB Director 10,000 $0.68 $6.8K $0 1 2019-03-18
EDGE Director — $49.66 — $0 3 2018-08-15
STRATA Skin Sciences, Inc. (MELA) Delisted CEO and President 67,570 — — $50.0K 2 2014-02-06
EPOCRATES INC (EPOC) Delisted President & CEO — — — $0 1 2011-03-28
Targanta Therapeutics Corp. (TARG) Delisted Director — — — $0 1 2008-08-26

Recent Filings

47 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-08 TEVA Exer (M) +14,492 $0 EDGAR
2026-06-01 TEVA Grant (A) — $0 EDGAR
2026-05-15 CERT Exer (M) +15,757 $0 EDGAR
2025-06-09 TEVA Mixed +9,632 $0 EDGAR
2025-05-22 CERT Mixed +11,928 $0 EDGAR
2024-06-25 TARS Exer (M) +3,350 $0 EDGAR
2024-06-17 TEVA Exer (M) +21,108 $0 EDGAR
2024-06-14 TARS Grant (A) — $0 EDGAR
2024-06-10 TEVA Grant (A) — $0 EDGAR
2024-05-23 CERT Mixed +8,663 $0 EDGAR
Showing 1–10 of 47
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.